Concepedia

A Physiologically Based Pharmacokinetic Model of Voriconazole Integrating Time-Dependent Inhibition of CYP3A4, Genetic Polymorphisms of CYP2C19 and Predictions of Drug–Drug Interactions

Xia Li, Sebastian Frechen, Daniel Moj, Thorsten Lehr, Max Taubert, Chih‐hsuan Hsin, Gerd Mikus, Pertti J. Neuvonen, Klaus T. Olkkola, Teijo I. Saari,

Clinical Pharmacokinetics · 2019 · 59 citations · 55 references

DOIFull text

Open access

Concepts

References

55

Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis

Raoul Herbrecht, David W. Denning, Thomas F. Patterson et al. · New England Journal of Medicine · 2002 · 3.3K citations · Full text

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

Andrew J. Ullmann, José María Aguado, David W. Denning et al. · Clinical Microbiology and Infection · 2018 · 1.5K citations · Full text

, , +6

The Original Michaelis Constant: Translation of the 1913 Michaelis–Menten Paper

Kenneth A. Johnson, Roger S. Goody · Biochemistry · 2011 · 1.4K citations

, , +19

Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes

Andrés Pascual, Thierry Calandra, S. Bolay et al. · Clinical Infectious Diseases · 2007 · 878 citations · Full text

Pharmacokinetic/Pharmacodynamic Profile of Voriconazole

Ursula Theuretzbacher, Franziska Ihle, Hartmut Derendorf · Clinical Pharmacokinetics · 2006 · 464 citations

, , +4